Menus Subscribe Search

Follow us


Class of Antipsychotics Ineffective in PTSD Treatment

• August 10, 2011 • 4:00 AM

The future may hold a drug therapy for treating post-traumatic stress disorder, but some of the popular choices of the last few years, like Risperdal, won’t be part of it.

A new era of psychopharmacology combined with two wars in Asia has created its own surge in treating combat stress with prescription drugs. For tough cases doctors have even prescribed antipsychotics. But all drugs are not created equal, and a new study claims that one class of antipsychotic is no better than a placebo for treating post-traumatic stress.

The study underlines that there is no drug for PTSD symptoms. The researchers concentrated on one medication, Risperdal, but the results may apply to a whole class of antipsychotics that work on neurotransmission in the brain.

“It definitely calls into question the use of anti-psychotics in general for PTSD,” Charles Hoge, a senior scientist at the Walter Reed Army Institute of Research, told The New York Times.

Antipsychotics like Risperdal target the way brain cells handle neurotransmitters like serotonin and dopamine. In that sense they’re similar to antidepressants. They ease a symptom that might correspond to PTSD, but recent research indicates that combat stress can cause physical damage to the brain. The cells themselves may have changed shape or started to work in a different way.

Basically, antipsychotics may affect the brain on too shallow a level to help. But there might be hope for drugs that try to fix cells on a level closer to a person’s genes.

“We don’t understand the disorder well enough. All we have are puzzle pieces,” says Dr. Ulrike Schmidt, a PTSD expert at the Max Planck Institute for Psychiatry in Munich. “But I can imagine that with more high-throughput experiments we will identify target genes, or the proteins they produce, which we can then try to steer with pharmaceuticals.”

Her opinion is that the right genes or proteins might be found roughly “in the household of stress hormones,” like cortisol.

Schmidt’s research has shown that PTSD causes semi-permanent damage not only to parts of the brain, but also to the epigenome, the complex of molecules that surrounds a person’s DNA and influences which genes are expressed. It’s like a blow to a person’s firmware — damage to a system that tells the body what to do. It’s not irreversible, though a predisposition for it could be passed on to another generation.

Antipsychotics — widely prescribed as they are — may seem off the mark because psychosis itself is not a typical outcome of post-traumatic stress (the way depression is). But symptoms of psychosis and PTSD can overlap. And doctors have been prescribing antipsychotics “based almost entirely on their experience with them and how they expect them to work,” according to the Times. [class name="dont_print_this"]

European Dispatch

EUROPEAN DISPATCH
Michael Scott Moore complements his standing feature in Miller-McCune magazine with frequent posts on the policy challenges and solutions popping up on the other side of the pond.

[/class]

The big caveat is that PTSD isn’t well understood. And some vets may have been prone to certain psychoses to start with. The current study didn’t select for them.

This research into molecules and brain behavior may wind up emphasizing that PTSD is too fine-grained and changeable to be treated entirely with drugs. As a disorder it seems to straddle the mysterious boundary between the mind and the brain. The simplest treatment — for most people — may still be sports, like surfing or biking, combined with talk therapy.

Schmidt helps run a clinic in Munich for people with severe post-traumatic stress, where the treatment involves drugs as well as therapy. “We have psychotherapy that includes depth psychology, gestalt therapy and behavioral-therapy elements. We never say, ‘Only behavioral therapy is good’ — we combine them. And we try to ease certain symptoms with medication. For example, a patient with severe sleeping problems might receive medication for that. … But the big goal is to lighten the therapy, or speed it up, with a PTSD-specific medication.”

One other non-pharmacological treatment, of course, would be to fight fewer wars.

Sign up for the free Miller-McCune.com e-newsletter.

“Like” Miller-McCune on Facebook.

Follow Miller-McCune on Twitter.

Add Miller-McCune.com news to your site.

Subscribe to Miller-McCune

Michael Scott Moore
Michael Scott Moore was a 2006-2007 Fulbright fellow for journalism in Germany, and The Economist named his surf travelogue, "Sweetness and Blood," a book of the year in 2010. His first novel, "Too Much of Nothing," was published by Carroll & Graf in 2003, and he’s written about politics and travel for The Atlantic Monthly, Slate, the Los Angeles Times, and Spiegel Online in Berlin, where he serves as editor-at-large.

More From Michael Scott Moore

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

September 30 • 4:00 AM

Grad School’s Mental Health Problem

Navigating the emotional stress of doctoral programs in a down market.


September 29 • 1:21 PM

Conference Call: Free Will Conference


September 29 • 12:00 PM

How Copyright Law Protects Art From Criticism

A case for allowing the copyright on Gone With the Wind to expire.


September 29 • 10:00 AM

Should We Be Told Who Funds Political Attack Ads?

On the value of campaign finance disclosure.


September 29 • 8:00 AM

Searching for a Man Named Penis

A quest to track down a real Penis proves difficult.


September 29 • 6:00 AM

Why Do So Many People Watch HGTV?

The same reason so many people watch NCIS or Law and Order: It’s all a procedural.


September 29 • 4:00 AM

The Link Between Depression and Terrorism

A new study from the United Kingdom finds a connection between depression and radicalization.


September 26 • 4:00 PM

Fast Track to a Spill?

Oil pipeline projects across America are speeding forward without environmental review.


September 26 • 2:00 PM

Why Liberals Love the Disease Theory of Addiction, by a Liberal Who Hates It

The disease model is convenient to liberals because it spares them having to say negative things about poor communities. But this conception of addiction harms the very people we wish to help.


September 26 • 1:21 PM

Race, Trust, and Split-Second Judgments


September 26 • 9:47 AM

Dopamine Might Be Behind Impulsive Behavior

A monkey study suggests the brain chemical makes what’s new and different more attractive.


September 26 • 8:00 AM

A Letter Becomes a Book Becomes a Play

Sarah Ruhl’s Dear Elizabeth: A Play in Letters From Elizabeth Bishop to Robert Lowell and Back Again takes 900 pages of correspondence between the two poets and turns them into an on-stage performance.


September 26 • 7:00 AM

Sonic Hedgehog, DICER, and the Problem With Naming Genes

Wait, why is there a Pokemon gene?


September 26 • 6:00 AM

Sounds Like the Blues

At a music-licensing firm, any situation can become nostalgic, romantic, or adventurous, given the right background sounds.


September 26 • 5:00 AM

The Dark Side of Empathy

New research finds the much-lauded feeling of identification with another person’s emotions can lead to unwarranted aggressive behavior.



September 25 • 4:00 PM

Forging a New Path: Working to Build the Perfect Wildlife Corridor

When it comes to designing wildlife corridors, our most brilliant analytical minds are still no match for Mother Nature. But we’re getting there.


September 25 • 2:00 PM

Fashion as a Inescapable Institution

Like it or not, fashion is an institution because we can no longer feasibly make our own clothes.


September 25 • 12:00 PM

The Fake Birth Mothers Who Bilk Couples Out of Their Cash by Promising Future Babies

Another group that’s especially vulnerable to scams and fraud is that made up of those who are desperate to adopt a child.


September 25 • 10:03 AM

The Way We QuickType


September 25 • 10:00 AM

There’s a Name for Why You Feel Obligated to Upgrade All of Your Furniture to Match

And it’s called the Diderot effect.


September 25 • 9:19 AM

School Counselors Do More Than You’d Think

Adding just one counselor to a school has an enormous impact on discipline and test scores, according to a new study.


September 25 • 9:05 AM

Sponsors: Coming to a Sports Jersey Near You

And really, it’s not that big of a deal.


September 25 • 8:00 AM

The Most Pointless Ferry in Maryland

Most of the some 200 ferries that operate in the United States serve a specific, essential purpose—but not the one that runs across the Tred Avon River.


September 25 • 7:00 AM

Hating Happiness

People all over the world are afraid of happiness, and that’s not necessarily a bad thing. It’s yet another challenge to the notion that positive thinking can heal all wounds.


Follow us


Dopamine Might Be Behind Impulsive Behavior

A monkey study suggests the brain chemical makes what's new and different more attractive.

School Counselors Do More Than You’d Think

Adding just one counselor to a school has an enormous impact on discipline and test scores, according to a new study.

How a Second Language Trains Your Brain for Math

Second languages strengthen the brain's executive control circuits, with benefits beyond words.

Would You Rather Go Blind or Lose Your Mind?

Americans consistently fear blindness, but how they compare it to other ailments varies across racial lines.

On the Hunt for Fake Facebook Likes

A new study finds ways to uncover Facebook Like farms.

The Big One

One company, Amazon, controls 67 percent of the e-book market in the United States—down from 90 percent five years ago. September/October 2014 new-big-one-5

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.